Th17 and regulatory T cells in patients with different time of progression of type 2 diabetes mellitus

Juan Manuel Guzmán-Flores; Joel Ramírez-Emiliano; Victoriano Pérez-Vázquez; Sergio López-Briones

doi:10.5114/ceji.2020.94670

Th17 and regulatory T cells in patients with different time of progression of type 2 diabetes mellitus

Cent Eur J Immunol. 2020;45(1):29-36. doi: 10.5114/ceji.2020.94670.

Authors

Juan Manuel Guzmán-Flores^{1

2}, Joel Ramírez-Emiliano¹, Victoriano Pérez-Vázquez¹, Sergio López-Briones³

Affiliations

¹ Department of Medical Sciences, Campus León, University of Guanajuato, León, Guanajuato, México.
² Department of Clinics, Los Altos University Center, University of Guadalajara, Tepatitlán de Morelos, Jalisco, Mexico.
³ Department of Medicine and Nutrition, Division of Health Sciences, Campus León, University of Guanajuato, Guanajuato, México.

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) is characterized by chronic inflammation, in which different types of immune cells participate, such as TH17 cells and Treg cells. The aim of this study was to determine the relationship between Treg and Th17 in patients with different times of T2DM progression.

Material and methods: Nineteen control subjects and 40 patients with T2DM were included. T2DM patients were classified into two groups: the first group consisted of twenty patients with less than10 years of disease progression (T2DM < 10), and the second group included 20 patients with a disease progression of 10 years or more (T2DM ≥ 10). Additionally, an analysis was performed according to the metabolic control, depending on HbA1c levels. The peripheral blood ratio of both Th17 and Treg cells was measured by standard flow cytometry protocols.

Results: No significant difference was found in Th17 cells of patients with T2DM < 10 or T2DM ≥ 10 and controls. With respect to CD4+CD25+FoxP3+ and CD4+CD25h Treg cells, a significant decrease was observed in patients with T2DM ≥ 10, mainly in patients with poor or moderate metabolic control. Statistical analysis performed in all patients with T2DM revealed a decrease in three cell subsets as well a negative correlation between Th17 cells and total cholesterol, CD4+CD25h cells with glucose and HbA1c levels, while a positive correlation was observed between CD4+CD25h cells and BMI.

Conclusions: A decrease on both Treg and Th17 cell subsets in T2DM patients was observed suggesting that the metabolic decontrol and the progression time of T2DM could modify the proportions of Th17 and Treg cells.

Keywords: Th17; Treg; diabetes mellitus.